Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy. Acta Haematol 2018;139(3):171-175

Date

03/30/2018

Pubmed ID

29597188

Pubmed Central ID

PMC6388419

DOI

10.1159/000487879

Scopus ID

2-s2.0-85045039013 (requires institutional sign-in at Scopus site)

Author List

Schneidewend R, Hosking P, Brazauskas R, Peterson J, Beaudin C, Michaelis L, Atallah E, Hari P, Carlson K

Authors

Ehab L. Atallah MD Professor in the Medicine department at Medical College of Wisconsin
Ruta Brazauskas PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Biomarkers, Tumor
Female
Genetic Markers
Humans
In Situ Hybridization, Fluorescence
Induction Chemotherapy
Leukemia, Myeloid, Acute
Male
Middle Aged
Odds Ratio
Young Adult